Literature DB >> 7441211

A new structural protein for Newcastle disease virus.

P Chambers, A C Samson.   

Abstract

Proteins induced in Newcastle disease virus (NDV)-infected chick embryo fibroblasts (CEF) and proteins incorporated into virions grown in ovo were analysed by modified versions of a two-dimensional polyacrylamide gel electrophoresis system. The following previously described NDV-induced proteins were detected and resolved from host proteins: L (mol. wt. approx. 200K), HN (75K), F0 (66K), F1 (56K), NP (55K) and M (39K). Two additional polypeptides, NAP (nucleocapsid-associated protein, mol. wt. 56K) and a 36K mol. wt. protein were induced in NDV-infected cells. NAP but not 36K was found in purified virions. Radioactive labelling studies with 3H-glucosamine and 32P-orthophosphate demonstrated that neither NAP nor 36K is glycosylated, but that both are phosphorylated. Variation in the isoelectric point and apparent mol. wt. of NAP among different strains was seen and exactly reproduced in both CEF and baby hamster kidney (BHK) cells. The synthesis of NDV-induced proteins including NAP and 36K was unaffected by actinomycin D, whereas the synthesis of host cell proteins was drastically reduced. These data are evidence that NAP and 36K are virus coded. Peptide analysis indicated that NAP, NP and F1 are unrelated polypeptides. The demonstration that NAP is virus coded, together with its phosphorylation and association with the nucleocapsid, suggest that NAP may be the NDV analogue of the P protein of Sendai virus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441211     DOI: 10.1099/0022-1317-50-1-155

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Cytolytic effects and apoptosis induction of Newcastle disease virus strain AF2240 on anaplastic astrocytoma brain tumor cell line.

Authors:  Rola Ali; Aied M Alabsi; Abdul Manaf Ali; Aini Ideris; Abdul Rahman Omar; Khatijah Yusoff; Riyadh Saif-Ali
Journal:  Neurochem Res       Date:  2011-06-14       Impact factor: 3.996

2.  Maturation of the envelope glycoproteins of Newcastle disease virus on cellular membranes.

Authors:  J C Schwalbe; L E Hightower
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

3.  Nucleotide sequence of the gene encoding the matrix protein of Newcastle disease virus.

Authors:  P Chambers; N S Millar; S G Platt; P T Emmerson
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

4.  UV irradiation analysis of complementation between, and replication of, RNA-negative temperature-sensitive mutants of Newcastle disease virus.

Authors:  M E Peeples; M A Bratt
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

5.  Coding assignments of the five smaller mRNAs of Newcastle disease virus.

Authors:  P L Collins; G W Wertz; L A Ball; L E Hightower
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

6.  Inhibitory and apoptosis-inducing effects of Newcastle disease virus strain AF2240 on mammary carcinoma cell line.

Authors:  Umar Ahmad; Ismaila Ahmed; Yong Yoke Keong; Nizar Abd Manan; Fauziah Othman
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

7.  Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus.

Authors:  K Yusoff; M Nesbit; H McCartney; P T Emmerson; A C Samson
Journal:  Virus Res       Date:  1988-11       Impact factor: 3.303

8.  Cellular CARD11 Inhibits the Fusogenic Activity of Newcastle Disease Virus via CBM Signalosome-Mediated Furin Reduction in Chicken Fibroblasts.

Authors:  Wenbin Wang; Qiaolin Wei; Qiqi Hao; Yajie Zhang; Yongshan Li; Youkun Bi; Zhongyuan Jin; Haijin Liu; Xuelan Liu; Zengqi Yang; Sa Xiao
Journal:  Front Microbiol       Date:  2021-02-02       Impact factor: 5.640

9.  Proteomic analysis of purified Newcastle disease virus particles.

Authors:  Xiangpeng Ren; Chunyi Xue; Qingming Kong; Chengwen Zhang; Yingzuo Bi; Yongchang Cao
Journal:  Proteome Sci       Date:  2012-05-09       Impact factor: 2.480

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.